Clinical trial
Randomized, Double Blind, Multicenter, Phase II/III Study to Evaluate the Effectiveness(Immunogenicity) and Safety of 'GC1107' Administered Intramuscularly in Healthy Children
NCT01402713 is registered in ClinicalTrials.gov with Green Cross Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized, Double Blind, Multicenter, Phase II/III Study to Evaluate the Effectiveness(Immunogenicity) and Safety of 'GC1107' Administered Intramuscularly in Healthy Children
- Lead sponsor
- Green Cross Corporation
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- August 31, 2011
- Completion date
- November 30, 2013
- Enrollment
- 311 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.